Advertisement Kamada receives US patent for Transferrin - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Kamada receives US patent for Transferrin

Israel-based Kamada has received the US patent for Transferrin, a highly purified human protein which functions as an iron carrier.

Kamada’s Transferrin has potential for utilization in the pharmaceutical industry as a targeting molecule for highly metabolizing cells with high iron requirement (cancerous or infected) cells. Kamada, which has been producing and marketing industrial quantities of high purity human Transferrin (Tf) for tissue culture use, is planning to develop a pharmaceutical product given its proprietary know-how and expertise.